55 related articles for article (PubMed ID: 7907393)
1. Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia.
Kaheled O; Aref S; El Menshawy N; Aref M; Ayed M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4301-4307. PubMed ID: 38156867
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia.
Pinto CM; Bertolucci CM; Severino AR; Dos Santos Tosi JF; Ikoma-Colturato MRV
Hematol Transfus Cell Ther; 2023 Nov; ():. PubMed ID: 38008596
[TBL] [Abstract][Full Text] [Related]
3. Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience.
Salem DA; Abd El-Aziz SM
Indian J Hematol Blood Transfus; 2012 Jun; 28(2):89-96. PubMed ID: 23730015
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.
Jen WY; Sasaki K; Loghavi S; Wang SA; Qiao W; Borthakur G; Ravandi F; Kadia TM; Issa GC; Short NJ; Yilmaz M; Daver NG; DiNardo CD
Br J Haematol; 2024 Apr; ():. PubMed ID: 38603594
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of CD14 positivity in acute myeloid leukemia arising from myelodysplastic syndrome.
Choi Y; Lee JH; Kim SD; Kim DY; Lee JH; Seol M; Kang YA; Jeon M; Jung AR; Lee KH
Int J Hematol; 2013 Feb; 97(2):246-55. PubMed ID: 23371544
[TBL] [Abstract][Full Text] [Related]
6. Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome.
Bhushan B; Chauhan PS; Saluja S; Verma S; Mishra AK; Siddiqui S; Kapur S
Clin Exp Med; 2010 Mar; 10(1):33-40. PubMed ID: 19779962
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.
Webber BA; Cushing MM; Li S
Int J Clin Exp Pathol; 2008 Jan; 1(2):124-33. PubMed ID: 18784805
[TBL] [Abstract][Full Text] [Related]
8. Significant association between expression of the CD11b surface molecule and favorable outcome for patients with acute myeloblastic leukemia.
Amirghofran Z; Zakerinia M; Shamseddin A
Int J Hematol; 2001 Jun; 73(4):502-506. PubMed ID: 11503966
[TBL] [Abstract][Full Text] [Related]
9. Sialic acids in molecular and cellular interactions.
Kelm S; Schauer R
Int Rev Cytol; 1997; 175():137-240. PubMed ID: 9203358
[TBL] [Abstract][Full Text] [Related]
10. The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.
Kelm S; Schauer R; Crocker PR
Glycoconj J; 1996 Dec; 13(6):913-26. PubMed ID: 8981082
[TBL] [Abstract][Full Text] [Related]
11. Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.
Stasi R; Taylor CG; Venditti A; Del Poeta G; Aronica G; Bastianelli C; Simone MD; Buccisano F; Cox MC; Bruno A
Ann Hematol; 1995 Jul; 71(1):13-27. PubMed ID: 7632814
[TBL] [Abstract][Full Text] [Related]
12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
13. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
[TBL] [Abstract][Full Text] [Related]
15. Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping.
Drexler HG
Leukemia; 1987 Oct; 1(10):697-705. PubMed ID: 3312833
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
17. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
